Cost-effectiveness of sequenced treatment of rheumatoid arthritis with targeted immune modulators.

about

Cost-effectiveness of sequenced treatment of rheumatoid arthritis with targeted immune modulators.

Item

http://www.wikidata.org/entity/Q38907286

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Cost-effectiveness of sequence ...... th targeted immune modulators.

@en

type

Item

label

Cost-effectiveness of sequence ...... th targeted immune modulators.

@en

prefLabel

Cost-effectiveness of sequence ...... th targeted immune modulators.

@en

P1476

Cost-effectiveness of sequence ...... th targeted immune modulators.

@en

P2093

Alex Mutebi

http://www.w3.org/2001/XMLSchema#string

Bradley Stolshek

http://www.w3.org/2001/XMLSchema#string

Desi Peneva

http://www.w3.org/2001/XMLSchema#string

Devin Incerti

http://www.w3.org/2001/XMLSchema#string

Joanna P MacEwan

http://www.w3.org/2001/XMLSchema#string

Mahdi Gharaibeh

http://www.w3.org/2001/XMLSchema#string

Primal Kaur

http://www.w3.org/2001/XMLSchema#string

Vibeke Strand

http://www.w3.org/2001/XMLSchema#string

P2860

Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II

The Employee Absenteeism Costs of Rheumatoid Arthritis: Evidence From US National Survey Data.

Evolution of direct costs in the first years of rheumatoid arthritis: impact of early versus late biologic initiation--an economic analysis based on the ESPOIR cohort.

The loss of health status in rheumatoid arthritis and the effect of biologic therapy: a longitudinal observational study.

A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries

Incidence, prevalence, costs, and impact on disability of common conditions requiring rehabilitation in the United States: stroke, spinal cord injury, traumatic brain injury, multiple sclerosis, osteoarthritis, rheumatoid arthritis, limb loss, and b

2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis.

Advances in the medical treatment of rheumatoid arthritis.

Coverage for high-cost specialty drugs for rheumatoid arthritis in Medicare Part D.

The relationship between EQ-5D, HAQ and pain in patients with rheumatoid arthritis.

P304

703-714

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/13696998.2017.1307205

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jeroen P Jansen

P577

2017-03-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28294642

http://www.w3.org/2001/XMLSchema#string